10 Health Care Stocks With Whale Alerts In Today's Session

BenzingaJan 14 12:35 ET

Reported Earlier, Praxis Announces 2025 Milestones: Advancing Relutrigine, Ulixacaltamide, And Rare Disease Programs With $470M In Cash Reserves

BenzingaJan 13 02:08 ET

Praxis Precision Medicines Highlights Late-Stage Clinical Trial Advancements and 2025 Milestones

Quiver QuantitativeJan 12 21:10 ET

Press Release: Praxis Precision Medicines Highlights 2025 Corporate Strategy and Business Priorities

Dow JonesJan 12 21:00 ET

Express News | Praxis Precision Medicines Highlights 2025 Corporate Strategy and Business Priorities

ReutersJan 12 21:00 ET

Praxis Precision Medicines to Present at J.P. Morgan Healthcare Conference

GlobeNewswireJan 6 08:00 ET